Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share Price

Price 8.00p on 12-09-2025 at 08:55:14
Change -0.30p -3.61%
Buy 8.50p
Sell 7.50p
Last Trade: Buy 5,126.00 at 8.075p
Day's Volume: 112,972
Last Close: 8.30p
Open: 8.50p
ISIN: GB00B02LCQ05
Day's Range 8.00p - 8.50p
52wk Range: 4.05p - 9.00p
Market Capitalisation: £381.32m
VWAP: 7.952322p
Shares in Issue: 4.77b

Allergy Thera. (AGY) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 5,126 8.075p Ordinary
09:55:12 - 12-Sep-25
Sell* 7,300 7.68p Ordinary
08:49:13 - 12-Sep-25
Sell* 7,500 7.68p Ordinary
08:40:30 - 12-Sep-25
Sell* 11,046 7.68p Ordinary
08:00:27 - 12-Sep-25
Buy* 5,000 8.50p Suspected BUY Trade
08:00:25 - 12-Sep-25
Buy* 8,000 8.30p Suspected BUY Trade
16:35:25 - 11-Sep-25
Buy* 5,000 8.50p Suspected BUY Trade
14:00:18 - 11-Sep-25
Buy* 3,600 8.35p Suspected BUY Trade
11:00:23 - 11-Sep-25
Sell* 455 7.50p SI Trade
09:12:21 - 11-Sep-25
Sell* 200 7.50p SI Trade
09:12:21 - 11-Sep-25
See more Allergy Thera. trades

Allergy Thera. (AGY) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Sep 2025 (Thu) 8.20 8.50 8.00 8.30 19,254
10th Sep 2025 (Wed) 8.00 8.00 7.75 8.00 479,093
9th Sep 2025 (Tue) 8.15 8.15 7.50 8.10 389,219
8th Sep 2025 (Mon) 8.00 8.50 8.00 8.35 66,412
5th Sep 2025 (Fri) 8.50 8.70 8.00 8.00 154,145
4th Sep 2025 (Thu) 8.50 8.50 8.00 8.50 189,991
3rd Sep 2025 (Wed) 8.50 8.50 8.00 8.50 67,114
2nd Sep 2025 (Tue) 8.50 9.00 8.00 8.50 127,774
1st Sep 2025 (Mon) 8.00 8.60 8.00 8.50 115,372
29th Aug 2025 (Fri) 8.00 8.00 7.85 7.85 135,991
28th Aug 2025 (Thu) 8.00 8.00 8.00 8.00 19,301
27th Aug 2025 (Wed) 8.00 8.00 8.00 8.00 257
26th Aug 2025 (Tue) 8.70 8.70 8.00 8.70 69,097
25th Aug 2025 (Mon) 8.70 8.70 8.70 8.70 0
22nd Aug 2025 (Fri) 8.75 8.75 8.00 8.70 27,894
21st Aug 2025 (Thu) 8.75 8.75 8.00 8.70 39,760
20th Aug 2025 (Wed) 8.75 8.75 8.00 8.70 37,008
19th Aug 2025 (Tue) 8.60 8.75 8.00 8.70 195,123
18th Aug 2025 (Mon) 8.60 8.60 8.00 8.40 254,285
15th Aug 2025 (Fri) 8.60 8.60 8.00 8.40 141,139
14th Aug 2025 (Thu) 8.00 8.40 8.00 8.40 257,674
13th Aug 2025 (Wed) 8.30 8.75 8.20 8.20 233,401
12th Aug 2025 (Tue) 8.25 8.25 8.00 8.25 60,231
See more Allergy Thera. price history

Allergy Thera. (AGY) Share News

Allergy Therapeutics shares slump as expects to post revenue decline

21st Jul 2025 13:47

(Alliance News) - Allergy Therapeutics PLC on Monday said it expects to report a small decline in earnings during its most recent financial year, as a result of regulatory changes within its key German market. Read More

LONDON MARKET OPEN: London stocks climb as miners and gold shine

21st Jul 2025 08:58

(Alliance News) - European equities were muted at the market open on Monday, beaten by the FTSE 100 as the index passed the 9,000 mark on a boost from miners. Read More

Allergy Therapeutics half-year loss narrows on lower expenses

31st Mar 2025 12:24

(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More

Allergy Therapeutics peanut allergy vaccine trial enters final phase

27th Mar 2025 18:27

(Alliance News) - Allergy Therapeutics PLC on Thursday said its peanut allergy vaccine trial has entered the final treatment phase. Read More

IN BRIEF: Allergy Therapeutics expects annual sales to rise on-year

28th Jan 2025 21:19

Allergy Therapeutics PLC - Sussex, England-based biotechnology company - Expects revenue to rise by 1.1%, or by 4% at constant currency, to GBP34.0 million in the six months ended December from GBP33.6 million a year ago. Sales are expected to continue to grow in the second half of the financial year. Overall, expects sales for the full year ending June 30 to exceed sales in the corresponding period ended June 2024. Reports cash position of GBP21.7 million at the end of December, rising from GBP12.9 million a year ago, following receipt of new GBP20 million five-year term loan. Chief Executive Manuel Llobet says: "We enter 2025 building strong momentum across all aspects of our business. Our return to first-half growth and strengthened position, having secured the Hayfin facility in late 2024, give us the confidence and financial stability to further our ambitious strategy." Read More

See more Allergy Thera. news
FTSE 100 Latest
Value9,324.52
Change26.94

Login to your account

Forgot Password?

Not Registered